03 OCT 2008 05:51 GI ACCRUAL REPORT - OPEN and recently closed STUDIES
REGS. REGS. REGS. REGS. REGS. # of # of
ACCR. TOTAL LAST LAST LAST LAST LAST ACTIVE CURRENT
STUDY REG. ARM GOAL REGS. 12 Months 6 Months 3 Months 30 DAYS 7 DAYS INSTs IRBs
-------- ---- -------------------------------- ------ ------ --------- -------- -------- ------- ------ ------ -------
S0502 1 1 Imatinib + Bevacizumab 572 1 1 1 1 1 0 113 38
2 Imatinib 1 1 1 1 0 0
------ --------- -------- -------- ------- ------
2 2 2 2 1 0
2 3 PET sub-study 572 1 1 1 1 1 0 113 38
------ --------- -------- -------- ------- ------
1 1 1 1 1 0
S0518 1 1 Octreotide, Bevacizumab 283 26 26 23 17 5 1 140 59
2 Octreotide,Interferon Alpha-2b 25 25 22 13 3 0
------ --------- -------- -------- ------- ------
51 51 45 30 8 1
2 3 Octreotide Scan Submission 283 26 26 24 15 6 1 140 59
------ --------- -------- -------- ------- ------
26 26 24 15 6 1
S0600 1 1 Cetuximab 1260 16 15 4 0 0 0 206 87
2 Cetuximab + Lower Bevacizumab 18 17 7 0 0 0
3 Cetuximab + Higher Bevacizumab 17 16 5 0 0 0
------ --------- -------- -------- ------- ------
51 48 16 0 0 0
S0727 1 1 Erlotinib+GEM+6 mg/kg IMC-A12 118 4 4 4 4 2 0 3 10
------ --------- -------- -------- ------- ------
4 4 4 4 2 0
C80101 1 Total Registrations 95 21 10 4 2 0 122
------ --------- -------- -------- ------- ------
95 21 10 4 2 0
C80405 1 Total Registrations 2289 422 159 41 0 0 0 318 157
------ --------- -------- -------- ------- ------
422 159 41 0 0 0
E5202 1 Total Registrations 223 104 52 25 9 3 173
------ --------- -------- -------- ------- ------
223 104 52 25 9 3
E5204 1 Total Registrations 65 41 17 12 5 0 247 120
------ --------- -------- -------- ------- ------
65 41 17 12 5 0
N0147 1 Total Registrations 504 183 55 2 2 0 187
------ --------- -------- -------- ------- ------
504 183 55 2 2 0
R04 1 Total Registrations 24 11 6 3 2 0 301 136
------ --------- -------- -------- ------- ------
24 11 6 3 2 0
16 rows selected.
no rows selected
no rows selected
SWOG StatCtr Home Page
1 row selected.